MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Karyopharm Therapeutics Company Profile (NASDAQ:KPTI)

Consensus Ratings for Karyopharm Therapeutics (NASDAQ:KPTI) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $40.14 (174.39% upside)

Analysts' Ratings History for Karyopharm Therapeutics (NASDAQ:KPTI)
Show:
DateFirmActionRatingPrice TargetActions
9/2/2015JPMorgan Chase & Co.Initiated CoverageOverweight$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2015WedbushLower Price TargetOutperform$50.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2015MLV & Co.Lower Price TargetBuy$54.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Leerink SwannLower Price TargetOutperform$58.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/17/2015Bank of AmericaInitiated CoverageNeutral$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015Leerink SwannReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015WedbushReiterated RatingOutperform$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Leerink SwannReiterated RatingOutperform$60.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Leerink SwannLower Price TargetOutperform$60.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015OppenheimerReiterated RatingOutperform$53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015MLV & Co.Reiterated RatingBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2014OppenheimerUpgradeMarket Perform -> Outperform$53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Barrington ResearchInitiated CoverageBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014MLV & Co.Initiated CoverageBuy$54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014WedbushInitiated CoverageOutperform$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Leerink SwannLower Price Target$63.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2014OppenheimerDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2014RBC CapitalLower Price TargetView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2014JMP SecuritiesBoost Price TargetOutperform$25.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2014Bank of AmericaBoost Price TargetBuy$40.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013JMP SecuritiesInitiated CoverageOutperform$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013Bank of AmericaInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013OppenheimerInitiated CoverageOutperform$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/3/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha